5-OMe-UDP trisodium saltPotent P2Y6 agonist CAS# 1207530-98-0 |
- Koumine
Catalog No.:BCN6190
CAS No.:1358-76-5
- Byakangelicol
Catalog No.:BCN5015
CAS No.:26091-79-2
- Obtusifolin
Catalog No.:BCN2537
CAS No.:477-85-0
- Gelsemine
Catalog No.:BCN5804
CAS No.:509-15-9
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 1207530-98-0 | SDF | Download SDF |
PubChem ID | 90488936 | Appearance | Powder |
Formula | C10H13N2Na3O13P2 | M.Wt | 500.13 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in water (supplied pre-dissolved at a concentration of 10mM) | ||
Chemical Name | trisodium;[[(2R,3S,4R,5R)-5-(2,6-dihydroxy-5-methoxy-3-methyl-1,3-diazinan-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] phosphate | ||
SMILES | CN1CC(C(N(C1O)C2C(C(C(O2)COP(=O)([O-])OP(=O)([O-])[O-])O)O)O)OC.[Na+].[Na+].[Na+] | ||
Standard InChIKey | IGMOCSFADHRLMQ-QAUZTDKFSA-K | ||
Standard InChI | InChI=1S/C11H24N2O13P2.3Na/c1-12-3-5(23-2)9(16)13(11(12)17)10-8(15)7(14)6(25-10)4-24-28(21,22)26-27(18,19)20;;;/h5-11,14-17H,3-4H2,1-2H3,(H,21,22)(H2,18,19,20);;;/q;3*+1/p-3/t5?,6-,7-,8-,9?,10-,11?;;;/m1.../s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Potent P2Y6 agonist (EC50 = 0.08 μM). Displays greater potency at P2Y6 than UDP (EC50 = 0.14 μM). |
5-OMe-UDP trisodium salt Dilution Calculator
5-OMe-UDP trisodium salt Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.9995 mL | 9.9974 mL | 19.9948 mL | 39.9896 mL | 49.987 mL |
5 mM | 0.3999 mL | 1.9995 mL | 3.999 mL | 7.9979 mL | 9.9974 mL |
10 mM | 0.1999 mL | 0.9997 mL | 1.9995 mL | 3.999 mL | 4.9987 mL |
50 mM | 0.04 mL | 0.1999 mL | 0.3999 mL | 0.7998 mL | 0.9997 mL |
100 mM | 0.02 mL | 0.1 mL | 0.1999 mL | 0.3999 mL | 0.4999 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- BMN 673
Catalog No.:BCC2205
CAS No.:1207456-01-6
- BMN-673 8R,9S
Catalog No.:BCC1422
CAS No.:1207456-00-5
- GDC-0349
Catalog No.:BCC1094
CAS No.:1207360-89-1
- GDC-mTOR inhibitor
Catalog No.:BCC1781
CAS No.:1207358-59-5
- BI-847325
Catalog No.:BCC6511
CAS No.:1207293-36-4
- NVS-CRF38
Catalog No.:BCC8059
CAS No.:1207258-55-6
- 12alpha-Hydroxyevodol
Catalog No.:BCN6102
CAS No.:120722-04-5
- Sarcandrolide D
Catalog No.:BCN6621
CAS No.:1207185-03-2
- Scutebata G
Catalog No.:BCN6101
CAS No.:1207181-63-2
- Scutebata F
Catalog No.:BCN6100
CAS No.:1207181-62-1
- Scutebata E
Catalog No.:BCN6099
CAS No.:1207181-61-0
- Scutebata C
Catalog No.:BCN6098
CAS No.:1207181-59-6
- LDV FITC
Catalog No.:BCC6229
CAS No.:1207610-07-8
- 3,2'-Epilarixinol
Catalog No.:BCN6496
CAS No.:1207671-28-0
- Huperzine A
Catalog No.:BCN1058
CAS No.:120786-18-7
- Gynosaponin I
Catalog No.:BCN4078
CAS No.:1207861-69-5
- Quassidine B
Catalog No.:BCN7022
CAS No.:1207862-37-0
- CaMKII-IN-1
Catalog No.:BCC5530
CAS No.:1208123-85-6
- VU 0365114
Catalog No.:BCC6164
CAS No.:1208222-39-2
- Ketone Ester
Catalog No.:BCC1677
CAS No.:1208313-97-6
- N6022
Catalog No.:BCC4127
CAS No.:1208315-24-5
- PF-03394197(Oclacitinib)
Catalog No.:BCC6474
CAS No.:1208319-26-9
- Isoliquiritin apioside
Catalog No.:BCN2914
CAS No.:120926-46-7
- FPL 64176
Catalog No.:BCC7050
CAS No.:120934-96-5
5-OMe-UDP is a potent and selective P2Y(6)-receptor agonist.[Pubmed:20095577]
J Med Chem. 2010 Feb 25;53(4):1673-85.
P2Y nucleotide receptors (P2Y-Rs) play important physiological roles. However, most of the P2Y-R subtypes are still lacking potent and selective agonists and antagonists. Based on data mining analysis of binding interactions in 44 protein-uridine nucleos(t)ides complexes, we designed uracil nucleotides, substituted at the C5/C6 position. All C6-substituted derivatives were inactive at the P2Y(2,4,6)-Rs, while out of the C5-substituted analogues, only 5-OMe-UD(T)P showed activity. To rationalize the data, the ionization and conformation of these analogues were evaluated. The pK(a) values of most analogues substituted at the C5/C6 positions were unaltered compared to UTP (pK(a) 9.42), except for 5-F-UTP nucleotide (pK(a) 7.85). C6-substituted analogues adopt the syn or high-syn conformations, which are disfavored by the receptors, while 5-OMe-UD(T)P adopt the favored anti conformation. Furthermore, 5-OMe-UDP adopts the S sugar puckering, which is the conformation preferred by the P2Y(6)-R, but not the P2Y(2)- or P2Y(4)-Rs. 5-OMe-UDP fulfills the conformational and H-bonding requirements of P2Y(6)-R, thus, making a potent P2Y(6)-R agonist (EC(50) 0.08 microM), more than UDP (EC(50) 0.14 microM).